Google has zaboravila advertising Klink, that proponuyut treatment with stovburova klutina

Google заборонила рекламу клінік, які пропонують лікування стовбуровими клітинами

Google namagala of zachistit their koristuvach from the “Sunny metodu treatment with stovburova klutina. Have compan Wasmachine, scho stink stop figure out marketplace Tim, hto “vykorystovuyutsia people propanoate m neferefre treatment”. Nova is Google dіє s ear grudnia. TL is Rosalina spline s Center s product control I Lomi (FDA) of the United States. Vaughn struggling W klinkama, that zastosowanie nedovolen I potentino nebezpecne methods treatment stovburova klutina. For data agencies, sotn clink on all country pocha vprovadzhuval therapy s vikoristannyam of stovburova Klin, that the FDA is not shalila Yak bezpecne efektivn. Google explained, scho RSN VD treatment by stovburova klutina znahoditsya on RSNA stages of development. Transplantation of stovburova Clin kostkova MOSCU good zarekomendovala yourself treatment method a number onkologiczna zakhvoryuvan. Ale z quietly z PR’yavylysya Novi treatment methods, yaki tilki pochinayut prohoditi clincin wirabuana. Although TSE, some clunky in USA vzhe proponuyut h clam. Tak clunky “hochut of ottimati Groshi Clit, ale mozhut not poyasnite, chomu h treatment methods General efektivn”, — zaznacza expert s boutiki Art Caplan, that ” zasnovnika vddlo medicine etiki in medychne faculty new Iorkskogo University. He naziva TSI clunky “escanda”, mauchi on Uvas, scho stink prelauch more pay attention komercine aktivnost, not real doomos pacta help our defenders. For ostan 15 years of galuzi of stovburova Clin Bulo inwestowania hope mlatv 20 dollars USA. Zrostannya number nesanktsionirovanno treatment privv to scho FDA pocas of podavati in court on ocram clunky. “South nedobrovol clunky, that christalina Clonie docey regenerative medicine, I give Amanov and nod I koronovan zapewnienia pacta, gruntowych on nedovedeniya, and according to vipadkah, nebezpechnih methods”, — said the FDA COMSAR Scott Gottlib

Share